Top Suppliers:I want be here
Related CAS#:
58553-56-3 1365762-81-7
858120-58-8 858120-57-7
111010-04-9 87205-04-7
1382490-99-4 54906-40-0
54906-42-2 152193-85-6
1220019-90-8 1220027-83-7
13601-24-6 681510-16-7
133243-83-1 1822737-80-3
1349715-76-9 1101067-42-8
935269-23-1 936845-94-2

58553-56-3

58553-56-3 structure
58553-56-3 structure
  • Name: 2,6-Naphthyridin-1(2H)-one, 3,4-dihydro-
  • Chemical Name: 3,4-dihydro-2H-2,6-naphthyridin-1-one
  • CAS Number: 58553-56-3
  • Molecular Formula: C8H8N2O
  • Molecular Weight: 148.16200
  • Create Date: 2017-06-16 19:36:05
  • Modify Date: 2025-08-23 23:04:11
Name 3,4-dihydro-2H-2,6-naphthyridin-1-one
Synonyms 3,4-dihydro-2H-[2,6]naphthyridin-1-one
Tetrahydro-2,6-naphthyridin-1-on
3,4-dihydro-2,6-naphthyridin-1(2H)-one
1,2,3,4-Tetrahydro-2,6-naphthyridin-1-on
1,2,3,4-TETRAHYDRO-2,6-NAPHTHYRIDIN-1-ONE
Molecular Formula C8H8N2O
Molecular Weight 148.16200
Exact Mass 148.06400
PSA 41.99000
LogP 0.69630
1365762-81-7 structure

1365762-81-7

~27%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 1018 ;
39931-77-6 structure

39931-77-6

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
3423-47-0 structure

3423-47-0

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
1365762-73-7 structure

1365762-73-7

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
3423-46-9 structure

3423-46-9

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
1365762-76-0 structure

1365762-76-0

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
4427-20-7 structure

4427-20-7

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
1365762-79-3 structure

1365762-79-3

~%

58553-56-3 structure

58553-56-3

Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1
58553-55-2 structure

58553-55-2

~%

58553-56-3 structure

58553-56-3

Literature: Meiji Seika Kaisha, Ltd. Patent: EP1180514 A1, 2002 ; Location in patent: Example 104 ;
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:58553-56-3 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 58553-56-3 | Chemsrc address: https://www.chemsrc.com/en/baike/1074035.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved